What it is
Selank is a synthetic heptapeptide based on tuftsin with a C-terminal extension. Developed at the Institute of Molecular Genetics (Russian Academy of Sciences).
Evidence snapshot
Category: Cognition. Status: Preclinical. See the references section below for the underlying primary sources.
Mechanism
Modulates serotonergic and BDNF expression. Also affects GABAergic signalling. Anxiolytic effects attributed to serotonin turnover modulation and BDNF upregulation.
Key research findings
Studied in rodent anxiety models and limited Russian clinical populations for generalised anxiety disorder and cognitive enhancement. Approved in Russia.
Limits of the evidence
Most published work is from Russian research groups. Independent replication outside Russia is sparse.